{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:41:42Z","timestamp":1791207702292,"version":"4.1.0"},"reference-count":89,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2007,8,3]],"date-time":"2007-08-03T00:00:00Z","timestamp":1186099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Francine and Louis Blumkin Foundation"},{"name":"Community Neuroscience Pride of Nebraska Research Initiative"},{"name":"Laboratory of Emerging Neuroscience Research"},{"name":"Alan Baer Charitable Trust"},{"name":"University of Nebraska Medical Center Graduate Student Excellence Award"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1T32 NS07488"],"award-info":[{"award-number":["1T32 NS07488"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1R21 NS049264"],"award-info":[{"award-number":["1R21 NS049264"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["2R37 NS36126"],"award-info":[{"award-number":["2R37 NS36126"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1 P01 NS043985-01"],"award-info":[{"award-number":["1 P01 NS043985-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5 P01 MH64570-03"],"award-info":[{"award-number":["5 P01 MH64570-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P20 RR15635"],"award-info":[{"award-number":["P20 RR15635"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Progressive loss of dopaminergic neurons in the substantia nigra pars compacta and their terminal connections in the striatum are central features in Parkinson\u2019s disease (PD). Emerging evidence supports the notion that microglia neuroinflammatory responses speed neurodegenerative events. We demonstrated previously that this can be slowed by adoptive transfer of T cells from Copolymer-1-immunized mice administered to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) recipients. The cellular basis for this neuroprotective response was the CD4+ T cell population, suggesting involvement of CD4+CD25+ regulatory T cells (Tregs), cells known to suppress immune activation and maintain immune homeostasis and tolerance. We show for the first time that adoptive transfer of CD3-activated Tregs to MPTP-intoxicated mice provides greater than 90% protection of the nigrostriatal system. The response was dose-dependent and paralleled modulation of microglial responses and up-regulation of glial cell-derived neurotrophic factor (CDNF) and TGF-\u03b2. Interestingly, that adoptive transfer of effector T cells showed no significant neuroprotective activities. Tregs were found to mediate neuroprotection through suppression of microglial responses to stimuli, including aggregated, nitrated \u03b1-synuclein. Moreover, Treg-mediated suppression was also operative following removal of Tregs from culture prior to stimulation. This neuroprotection was achieved through modulation of microglial oxidative stress and inflammation. As Tregs can be modulated in vivo, these data strongly support the use of such immunomodulatory strategies to treat PD.<\/jats:p>","DOI":"10.1189\/jlb.0507296","type":"journal-article","created":{"date-parts":[[2007,8,3]],"date-time":"2007-08-03T21:45:03Z","timestamp":1186177503000},"page":"1083-1094","source":"Crossref","is-referenced-by-count":374,"title":["Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson\u2019s disease"],"prefix":"10.1093","volume":"82","author":[{"given":"Ashley D","family":"Reynolds","sequence":"first","affiliation":[{"name":"Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center , Omaha, Nebraska , USA"},{"name":"Department of Pharmacology and Experimental Neuroscience , Omaha, Nebraska , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center , Omaha, Nebraska , USA"},{"name":"Department of Pharmacology and Experimental Neuroscience , Omaha, Nebraska , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianou","family":"Liu","sequence":"additional","affiliation":[{"name":"Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center , Omaha, Nebraska , USA"},{"name":"Department of Pharmacology and Experimental Neuroscience , Omaha, Nebraska , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard E","family":"Gendelman","sequence":"additional","affiliation":[{"name":"Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center , Omaha, Nebraska , USA"},{"name":"Department of Pharmacology and Experimental Neuroscience , Omaha, Nebraska , USA"},{"name":"Department of Internal Medicine, University of Nebraska Medical Center , Omaha, Nebraska , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Lee Mosley","sequence":"additional","affiliation":[{"name":"Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center , Omaha, Nebraska , USA"},{"name":"Department of Pharmacology and Experimental Neuroscience , Omaha, Nebraska , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,8,3]]},"reference":[{"key":"2023033006294471700_","article-title":"Merritt\u2019s Neurology","author":"Fahn","year":"2000"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","article-title":"Diagnosis and treatment of Parkinson disease: molecules to medicine","volume":"116","author":"Savitt","year":"2006","journal-title":"J. Clin. Invest."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1055\/s-2006-951621","article-title":"Clinical implications of Parkinson\u2019s disease genetics","volume":"26","author":"Lorincz","year":"2006","journal-title":"Semin. Neurol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"E606","DOI":"10.1208\/aapsj080369","article-title":"Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson\u2019s disease","volume":"8","author":"Liu","year":"2006","journal-title":"AAPS J."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jneuroim.2006.03.027","article-title":"Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases","volume":"176","author":"Dhib-Jalbut","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"2023033006294471700_","first-page":"147","article-title":"Nongenetic causes of Parkinson\u2019s disease","volume":"2006","author":"Chade","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0925-4439(97)00070-7","article-title":"Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson\u2019s disease","volume":"1362","author":"Cassarino","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"2023033006294471700_","first-page":"215","article-title":"Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration","volume":"53","author":"Suzuki","year":"1990","journal-title":"Adv. Neurol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(95)00596-I","article-title":"Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson\u2019s disease","volume":"691","author":"Yoshimoto","year":"1995","journal-title":"Brain Res."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/neur.1996.0020","article-title":"Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson\u2019s disease mice model","volume":"5","author":"Czlonkowska","year":"1996","journal-title":"Neurodegeneration"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0736-5748(00)00012-5","article-title":"Induction of cytokines in glial cells surrounding cortical \u03b2-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology","volume":"18","author":"Mehlhorn","year":"2000","journal-title":"Int. J. Dev. Neurosci."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0960-9822(98)70016-8","article-title":"Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus","volume":"8","author":"Rogove","year":"1998","journal-title":"Curr. Biol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1471-4159.2006.04315.x","article-title":"Ion channel blockade attenuates aggregated \u03b1 synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson\u2019s disease","volume":"100","author":"Thomas","year":"2007","journal-title":"J. Neurochem."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1073\/pnas.0400569101","article-title":"Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease","volume":"101","author":"Benner","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jneuroim.2006.11.009","article-title":"CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"183","author":"Laurie","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J. Neurochem."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI200318797","article-title":"D-\u03b2-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease","volume":"112","author":"Tieu","year":"2003","journal-title":"J. Clin. Invest."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/meth.1998.0688","article-title":"Microglia in cell culture and in transplantation therapy for central nervous system disease","volume":"16","author":"Dobrenis","year":"1998","journal-title":"Methods"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/intimm\/dxh165","article-title":"Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells","volume":"16","author":"Yagi","year":"2004","journal-title":"Int. Immunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/311464a0","article-title":"Intraneuronal generation of a pyridinium metabolite may cause drug-induced Parkinsonism","volume":"311","author":"Markey","year":"1984","journal-title":"Nature"},{"key":"2023033006294471700_","first-page":"1000","article-title":"Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: systemic administration","volume":"270","author":"Giovanni","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/em.10133","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced lipid peroxidation and DNA damage in mouse bone marrow and blood","volume":"41","author":"Ortiz","year":"2003","journal-title":"Environ. Mol. Mutagen."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/B:JOBB.0000041771.66775.d5","article-title":"MPTP as a mitochondrial neurotoxic model of Parkinson\u2019s disease","volume":"36","author":"Przedborski","year":"2004","journal-title":"J. Bioenerg. Biomembr."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"4","author":"Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0074-7742(07)82016-2","article-title":"Oxidative stress and the pathogenesis of neurodegenerative disorders","volume":"82","author":"Reynolds","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1523\/JNEUROSCI.4364-04.2005","article-title":"Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson\u2019s disease","volume":"25","author":"Boska","year":"2005","journal-title":"J. Neurosci."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"11472","DOI":"10.1073\/pnas.97.21.11472","article-title":"Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1","volume":"97","author":"Aharoni","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1073\/pnas.0502187102","article-title":"Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3","volume":"102","author":"Hong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl. 2","key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"14663","DOI":"10.1073\/pnas.0404842101","article-title":"Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia","volume":"101","author":"Kipnis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0006-8993(01)02681-6","article-title":"Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum","volume":"909","author":"He","year":"2001","journal-title":"Brain Res."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1096\/fj.05-5106com","article-title":"Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-\u03b1","volume":"20","author":"Sriram","year":"2006","journal-title":"FASEB J."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson\u2019s disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0006-8993(00)02072-2","article-title":"Early microglial reaction following mild forebrain ischemia induced by common carotid artery occlusion in rats","volume":"862","author":"Abraham","year":"2000","journal-title":"Brain Res."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jnr.20870","article-title":"Comparative study of microglia activation induced by amyloid-\u03b2 and prion peptides: role in neurodegeneration","volume":"84","author":"Garcao","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"2023033006294471700_","first-page":"87","article-title":"Early immunohistochemical detection of axonal damage and glial activation in extremely immature brains with periventricular leukomalacia","volume":"20","author":"Hirayama","year":"2001","journal-title":"Clin. Neuropathol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1128\/jvi.69.3.1408-1419.1995","article-title":"Induction of focal spongiform neurodegeneration in developmentally resistant mice by implantation of murine retrovirus-infected microglia","volume":"69","author":"Lynch","year":"1995","journal-title":"J. Virol."},{"key":"2023033006294471700_","first-page":"83","article-title":"Inflammation in Parkinson\u2019s disease","volume":"86","author":"McGeer","year":"2001","journal-title":"Adv. Neurol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1093\/brain\/awh625","article-title":"A possible role for humoral immunity in the pathogenesis of Parkinson\u2019s disease","volume":"128","author":"Orr","year":"2005","journal-title":"Brain"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00427222","article-title":"Lewy bodies in Parkinson\u2019s disease are recognized by antibodies to complement proteins","volume":"84","author":"Yamada","year":"1992","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated \u03b1-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1523\/JNEUROSCI.0970-05.2005","article-title":"Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson\u2019s disease in mice","volume":"25","author":"Choi","year":"2005","journal-title":"J. Neurosci."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.intimp.2004.05.006","article-title":"Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson\u2019s disease","volume":"4","author":"Kurkowska-Jastrzebska","year":"2004","journal-title":"Int. Immunopharmacol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"14669","DOI":"10.1073\/pnas.251341998","article-title":"Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease","volume":"98","author":"Du","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-3-6","article-title":"Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson\u2019s disease","volume":"3","author":"Vijitruth","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson\u2019s disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U","article-title":"Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson\u2019s disease","volume":"39","author":"Teismann","year":"2001","journal-title":"Synapse"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20682","article-title":"Nonsteroidal antiinflammatory drug use and the risk for Parkinson\u2019s disease","volume":"58","author":"Chen","year":"2005","journal-title":"Ann. Neurol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease","volume":"60","author":"Chen","year":"2003","journal-title":"Arch. Neurol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20020399","article-title":"Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"196","author":"Hoffmann","year":"2002","journal-title":"J. Exp. Med."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/art.21195","article-title":"Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells","volume":"52","author":"Morgan","year":"2005","journal-title":"Arthritis Rheum."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.4049\/jimmunol.171.5.2270","article-title":"Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion","volume":"171","author":"Goudy","year":"2003","journal-title":"J. Immunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.4049\/jimmunol.171.10.5012","article-title":"CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-\u03b2, and CTLA4","volume":"171","author":"Liu","year":"2003","journal-title":"J. Immunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4049\/jimmunol.170.1.394","article-title":"CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice","volume":"170","author":"Xu","year":"2003","journal-title":"J. Immunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor \u03b1-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.20051060","article-title":"Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis","volume":"202","author":"Beyersdorf","year":"2005","journal-title":"J. Exp. Med."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.4049\/jimmunol.169.9.4712","article-title":"Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis","volume":"169","author":"Kohm","year":"2002","journal-title":"J. Immunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/brain\/awl213","article-title":"Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis","volume":"129","author":"Tischner","year":"2006","journal-title":"Brain"},{"key":"2023033006294471700_","first-page":"2434","article-title":"Role of IFN-\u03b3 in induction of Foxp3 and conversion of CD4 CD25 T cells to CD4 Tregs","volume":"116","author":"Wang","year":"2006","journal-title":"J. Clin. Invest."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jns.2005.03.022","article-title":"Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke","volume":"233","author":"Frenkel","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1172\/JCI12837","article-title":"Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease","volume":"108","author":"Hauben","year":"2001","journal-title":"J. Clin. Invest."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1523\/JNEUROSCI.20-17-06421.2000","article-title":"Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion","volume":"20","author":"Hauben","year":"2000","journal-title":"J. Neurosci."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1523\/JNEUROSCI.0406-04.2004","article-title":"Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats","volume":"24","author":"Jones","year":"2004","journal-title":"J. Neurosci."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1523\/JNEUROSCI.22-07-02690.2002","article-title":"Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy","volume":"22","author":"Jones","year":"2002","journal-title":"J. Neurosci."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0165-5728(02)00219-9","article-title":"Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity","volume":"130","author":"Kipnis","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.1073\/pnas.97.13.7446","article-title":"T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies","volume":"97","author":"Kipnis","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/4734","article-title":"Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy","volume":"5","author":"Moalem","year":"1999","journal-title":"Nat. Med."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0165-5728(02)00367-3","article-title":"Neuroprotection by T-cells depends on their subtype and activation state","volume":"133","author":"Wolf","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","article-title":"Alterations of T-lymphocyte populations in Parkinson disease","volume":"11","author":"Baba","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-5728(00)00422-7","article-title":"Lymphocyte populations in Parkinson\u2019s disease and in rat models of Parkinsonism","volume":"113","author":"Bas","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.20020556","article-title":"Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis","volume":"196","author":"Kullberg","year":"2002","journal-title":"J. Exp. Med."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.immuni.2006.03.019","article-title":"Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells","volume":"24","author":"Wang","year":"2006","journal-title":"Immunity"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol. Rev."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.164.1.183","article-title":"Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific","volume":"164","author":"Thornton","year":"2000","journal-title":"J. Immunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X","article-title":"CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells","volume":"30","author":"Cederbom","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4049\/jimmunol.160.3.1212","article-title":"CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells","volume":"160","author":"Suri-Payer","year":"1998","journal-title":"J. Immunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1002\/eji.200424883","article-title":"Vaccination with autoantigen protects against aggregated \u03b2-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells","volume":"34","author":"Avidan","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4049\/jimmunol.172.2.834","article-title":"TGF-\u03b2 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice","volume":"172","author":"Nakamura","year":"2004","journal-title":"J. Immunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1084\/jem.194.5.629","article-title":"Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor \u03b2","volume":"194","author":"Nakamura","year":"2001","journal-title":"J. Exp. Med."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/intimm\/14.2.233","article-title":"Natural CD4 CD25(+) regulatory T cells control the burst of superantigen-induced cytokine production: the role of IL-10","volume":"14","author":"Pontoux","year":"2002","journal-title":"Int. Immunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4049\/jimmunol.177.1.40","article-title":"Cutting edge: induction of B7\u2013H4 on APCs through IL-10: novel suppressive mode for regulatory T cells","volume":"177","author":"Kryczek","year":"2006","journal-title":"J. Immunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.neurobiolaging.2006.04.011","article-title":"Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra","volume":"28","author":"Arimoto","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.4049\/jimmunol.172.11.7015","article-title":"TGF-\u03b21 represses activation and resultant death of microglia via inhibition of phosphatidylinositol 3-kinase activity","volume":"172","author":"Kim","year":"2004","journal-title":"J. Immunol."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/j.1460-2075.1995.tb07052.x","article-title":"TGF-\u03b2 superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity","volume":"14","author":"Krieglstein","year":"1995","journal-title":"EMBO J."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mcn.2005.10.006","article-title":"Microglia activated by IL-4 or IFN-\u03b3 differentially induce neurogenesis and oligodendrogenesis from adult stem\/progenitor cells","volume":"31","author":"Butovsky","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"2023033006294471700_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.55782\/ane-1999-1289","article-title":"MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson\u2019s disease","volume":"59","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Acta Neurobiol. Exp. (Wars)"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1189%2Fjlb.0507296","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/82\/5\/1083\/49638567\/jlb1083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/82\/5\/1083\/49638567\/jlb1083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T02:36:18Z","timestamp":1708137378000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/82\/5\/1083\/6975839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,3]]},"references-count":89,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,8,3]]},"published-print":{"date-parts":[[2007,11,1]]}},"URL":"https:\/\/doi.org\/10.1189\/jlb.0507296","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,11]]},"published":{"date-parts":[[2007,8,3]]}}}